Why are Laos Lucius Pharmaceuticals products recognized by patients?

Lucius Pharmaceuticals, a leading generic drug company in Laos, has a good reputation among patients. Why are Lucius Pharmaceuticals products recognized by patients and doctors? After visiting and understanding, the author has the following aspects.

1. Efficacy and quality
2. The efficacy is similar to the original drug: From some clinical feedback and research, some generic drugs of Lucius in Laos are basically equivalent to the original drug in terms of efficacy. For example, the generic drug of Ixazomib can effectively inhibit proteasome activity like the original drug and relieve the symptoms of multiple myeloma.
3. Strictly follow the production standards: Lucius Pharmaceuticals invested in the construction of Asia Pacific No. 1 Smart Factory in Vientiane, the capital of Laos, following the GMP production standards, introducing the world’s top pharmaceutical equipment from China, the United States, Germany, etc., and established an international high-end preparation workshop. Each stage has strict quality control and inspection.
4. Guaranteed drug qualifications and quality: It produces more than 120 drugs, such as the Lao Lucius version of Wansaiwei and Adagelasib generic drugs, which have been officially approved by the Lao government and are legal and formal drugs certified by the Lao Ministry of Health. In addition, there are Chinese technical standards and technology output of the Belt and Road Initiative. The quality of Lucius products reaches or is comparable to the popular international standards.

Lucius Pharmaceuticals, a leading company in Lao generic drugs

2. Price

The price of Lao Lucius Pharmaceuticals’ products is much lower than that of original drugs, with extremely high cost performance, which greatly reduces the economic burden of patients. For example, the price of Adagelasib generic drugs is about four or five thousand, which is much lower than that of original drugs.

3. Product diversity

The product variety is rich, covering more than 200 categories such as anti-tumor, cardiovascular, blood, diabetes, skin diseases, men’s health, anti-aging, etc. Most of them are emerging advanced innovative drugs in recent years, which can meet the needs of different patients.

IV. Enterprise development and cooperation

1. Technology introduction and breakthrough: Under the promotion of the “Belt and Road” initiative, we actively introduce Chinese technology and advanced pharmaceutical processes, strengthen technical cooperation with China, Europe, the United States and other parties, and achieve key generic drug technology breakthroughs.
2. Market and reputation: After nearly ten years of development, our products have been sold well in more than 50 countries and regions around the world, and we have become one of the world’s patented generic drug research and development powerhouses, with a good reputation and market reputation in the industry.